[The effect of prazosin and korinfar on the central hemodynamics and liver blood flow in hypertension patients (based on 2-dimensional Doppler echography)]. 1991

N F Beresten', and Iu F Sakhno, and R G Shengeliia, and T E Dobrotvorskaia

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011224 Prazosin A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. Furazosin,Minipress,Pratsiol,Prazosin HCL,Prazosin Hydrochloride,HCL, Prazosin,Hydrochloride, Prazosin
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

N F Beresten', and Iu F Sakhno, and R G Shengeliia, and T E Dobrotvorskaia
May 1985, Kardiologiia,
N F Beresten', and Iu F Sakhno, and R G Shengeliia, and T E Dobrotvorskaia
July 1990, Vrachebnoe delo,
N F Beresten', and Iu F Sakhno, and R G Shengeliia, and T E Dobrotvorskaia
January 1987, ORL; journal for oto-rhino-laryngology and its related specialties,
N F Beresten', and Iu F Sakhno, and R G Shengeliia, and T E Dobrotvorskaia
January 1988, Hepatology (Baltimore, Md.),
N F Beresten', and Iu F Sakhno, and R G Shengeliia, and T E Dobrotvorskaia
January 1989, Farmakologiia i toksikologiia,
N F Beresten', and Iu F Sakhno, and R G Shengeliia, and T E Dobrotvorskaia
January 1993, Likars'ka sprava,
N F Beresten', and Iu F Sakhno, and R G Shengeliia, and T E Dobrotvorskaia
February 1984, Kardiologiia,
N F Beresten', and Iu F Sakhno, and R G Shengeliia, and T E Dobrotvorskaia
January 1991, Farmakologiia i toksikologiia,
N F Beresten', and Iu F Sakhno, and R G Shengeliia, and T E Dobrotvorskaia
August 1984, Kardiologiia,
N F Beresten', and Iu F Sakhno, and R G Shengeliia, and T E Dobrotvorskaia
March 1990, Orvosi hetilap,
Copied contents to your clipboard!